Literature DB >> 19840864

TLRs and chronic inflammation.

Caroline Ospelt1, Steffen Gay.   

Abstract

After the discovery of Toll-like receptors (TLRs), innate immune mechanisms came back in the focus of scientific research. With more and more mechanisms of TLR biology known, it has become clear that these and also other innate immune receptors are not only of crucial importance in the immune response to invading pathogens, but also play a role in the homeostasis of commensal flora and in the response to stress and danger signals. In this respect, increasing evidence is found that inappropriate quantity or quality of TLR ligands or aberrant response to TLR activation plays a role in a variety of chronic inflammatory diseases. In this review, an overview of the currently known TLRs and their signaling pathways is given and reports about their expression and activation in chronic inflammatory diseases are recapitulated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840864     DOI: 10.1016/j.biocel.2009.10.010

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  57 in total

Review 1.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 2.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

Review 3.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

4.  The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators.

Authors:  Whitney Valins; Sadegh Amini; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

5.  Transcriptional Profiling of the Chicken Tracheal Response to Virulent Mycoplasma gallisepticum Strain Rlow.

Authors:  J Beaudet; E R Tulman; K Pflaum; X Liao; G F Kutish; S M Szczepanek; L K Silbart; S J Geary
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

6.  TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.

Authors:  Marcela Alcântara Proença; Juliana Garcia de Oliveira; Aline Cristina Targa Cadamuro; Maysa Succi; João Gomes Netinho; Eny Maria Goloni-Bertolo; Érika Cristina Pavarino; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

7.  Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.

Authors:  Hong Yang; Shan Yu Fung; Aihua Bao; Qiang Li; Stuart E Turvey
Journal:  J Vis Exp       Date:  2017-07-26       Impact factor: 1.355

8.  Trehalose alleviates PC12 neuronal death mediated by lipopolysaccharide-stimulated BV-2 cells via inhibiting nuclear transcription factor NF-κB and AP-1 activation.

Authors:  Qing He; Ying Wang; Wei Lin; Qiong Zhang; Jue Zhao; Feng-Tao Liu; Yi-Lin Tang; Bao-Guo Xiao; Jian Wang
Journal:  Neurotox Res       Date:  2014-08-15       Impact factor: 3.911

Review 9.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

Review 10.  Biological interplay between proteoglycans and their innate immune receptors in inflammation.

Authors:  Helena Frey; Nina Schroeder; Tina Manon-Jensen; Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2013-02-21       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.